Durvalumab in Combination With Olaparib Versus Durvalumab Alone as Maintenance Therapy in Metastatic NSCLC: The Phase 2 ORION Study

Autor: Ahn, Myung-Ju, Bondarenko, Igor, Kalinka, Ewa, Cho, Byoung Chul, Sugawara, Shunichi, Gálffy, Gabriella, Shim, Byoung Yong, Kislov, Nikolay, Nagarkar, Rajnish, Demedts, Ingel, Gans, Steven J.M., Mendoza Oliva, Dolores, Stewart, Ross, Lai, Zhongwu, Mann, Helen, Shi, Xiaojin, Hussein, Maen
Zdroj: In Journal of Thoracic Oncology November 2023 18(11):1594-1606
Databáze: ScienceDirect